Taurine for Blood Pressure Regulation

Research suggests that taurine may play a meaningful role in blood pressure regulation through multiple biological pathways, including direct effects on cardiovascular tissue, modulation of inhibitory neurotransmitter activity in brain regions that govern vasomotor tone, and indirect effects through bile acid metabolism. Animal studies — including work in spontaneously hypertensive rats dating back to the 1980s — consistently show that taurine supplementation reduces blood pressure and associated organ damage, while more recent research points to mechanisms involving brain regions such as the rostral ventrolateral medulla and the hypothalamic paraventricular nucleus, where taurine and related compounds appear to dampen overactive nerve signaling. The available human evidence is considerably thinner, consisting largely of observational data and reviews rather than randomized controlled trials, and a 2016 prospective cohort study found no statistically significant association between circulating taurine levels and stroke risk in the overall population, though a potentially protective signal emerged in a subgroup of never-smokers. Taken together, the body of evidence — which is weighted heavily toward animal and mechanistic studies — is directionally supportive but not yet sufficient to draw firm conclusions about taurine's role in human blood pressure management, and several of the provided sources address topics such as gut microbiota, cardiac aging, and antiviral mechanisms that are too peripheral to taurine's cardiovascular effects to substantially inform this question.